生物仿制药
估价(财务)
业务
财务
精算学
生物技术
生物
作者
Ronak Patel,Tulip Nuwal
标识
DOI:10.1080/14737167.2022.2072830
摘要
Biosimilar development candidate selection requires a thorough financial evaluation considering product-, company- and market-specific aspects.
科研通智能强力驱动
Strongly Powered by AbleSci AI